Medicare HMO costs may prevent cancer patient clinical trial participation
Sunday, October 5, 2008 - 23:35
in Health & Medicine
Newly diagnosed cancer patients who are enrolled in Medicare's Health Maintenance Organisation (HMO) plans may be unlikely to participate in clinical trials because of prohibitive costs, according to a study by the University of Pittsburgh Cancer Institute...
Read the whole article on Science Centric
More from Science Centric
Related
- One in ten advanced colon cancer patients worry about prescription drug costsFri, 29 May 2009, 11:11:10 EDT
- Project Zero Delay accelerates drug's path to clinical trialMon, 3 Aug 2009, 16:24:58 EDT
- National call for cancer clinical trial system to be more responsive to community needsTue, 11 Nov 2008, 12:53:49 EST
- Mayo researchers: Dramatic outcomes in prostate cancer studyFri, 19 Jun 2009, 15:11:50 EDT
- Results from TH-302 clinical trials presented at international lung cancer meetingThu, 6 Aug 2009, 17:30:56 EDT